Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2009) 23 OC3.8

BSPED2009 Oral Communications Oral Communications 3 (8 abstracts)

Determinants of remission and relapse in a cohort of children with thyrotoxicosis treated with dose titration of carbimazole

Indi Banerjee 1 , Rakesh Amin 1 , Elizabeth Okecha 1 , Anbu Subbarayan 1 , Mars Skae 1 , Catherine Hall 1 , Helena Gleeson 1 , Sarah Ehtisham 1 , Leena Patel 2 & Peter Clayton 2


1Royal Manchester Children’s Hospital, Manchester, UK; 2University of Manchester, Manchester, UK.


Introduction: Factors determining remission and relapse in children with thyrotoxicosis include ethnicity, age and thyroid hormone levels at diagnosis. We investigated if similar factors influence remission and relapse in a contemporary cohort of children with autoimmune thyrotoxicosis treated by dose titration of carbimazole.

Methods: Forty-seven children (39 females) with thyrotoxicosis, treated with carbimazole, were followed up for ≥2 years. Initial remission was defined as first cessation of carbimazole and long term remission was defined if remission lasted >2 years. Relapse was defined as recommencement of carbimazole following remission or a dose increment on existing treatment.

Results: First remission was achieved in 28 (60%) children after a median (range) of 1.5 (0.3, 3.1) years after diagnosis, while long-term remission was achieved in 8 (17%). Relapse occurred in 37 (78%) children 1.9 (0.2, 6.7) years after diagnosis. Following remission, relapse occurred in 20 (71%) children, while remission after relapse was rare at 14%. Treatment with surgery or radiotherapy was given to 22 (46%) children. In survival analysis, risk of relapse was associated with a lower body mass index at diagnosis (hazard ratio (HR) (95% confidence interval) 14.5 (1.6, 126.2), P=0.02) and a higher dose of carbimazole 6 months after diagnosis (HR 1.17 (1.0, 1.3), P=0.03) but not with non-Caucasian ethnicity, younger age or high serum free thyroxine levels. In linear regression (R2=0.68, P=0.02), time between initial remission and relapse was negatively correlated with time to achieve initial remission (P=0.002) and initial dose of carbimazole (P=0.01), when controlling for ethnicity, age, sex and weight, suggesting an association of greater disease severity with a higher risk of relapse.

Conclusion: Most children with thyrotoxicosis treated with dose titration of carbimazole relapse after remission, especially if they are thin at diagnosis and remain on high treatment doses at 6 months after diagnosis.

Volume 23

37th Meeting of the British Society for Paediatric Endocrinology and Diabetes

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.